Arab Journal of Gastroenterology
Volume 10, Issue 4, Supplement , Pages S17-S20 , April 2010

Pathology of NASH and fibrosis

References 

  1. Agarwal SR, Malhotra V, Sakhuja P, et al. Clinical, biochemical and histological profile of nonalcoholic steatohepatitis. Indian J Gastroenterol. 2001;20(5):183–186
  2. Aleffi S, Petrai I, Bertolani C, et al. Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells. Hepatology. 2005;42(6):1339–1348
  3. Brunt EM, Janney CG, Di Bisceglie AM, et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94(9):2467–2474
  4. Chitturi S, Abeygunasekera S, Farrell GC, et al. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology. 2002;35(2):373–379
  5. Contos MJ, Choudhury J, Mills AS, et al. The histologic spectrum of nonalcoholic fatty liver disease. Clin Liver Dis 2004;8(3):481–500 [vii].
  6. Cortez-Pinto H, Baptista A, Camilo ME, et al. Hepatic stellate cell activation occurs in nonalcoholic steatohepatitis. Hepatogastroenterology. 2001;48(37):87–90
  7. Diehl AM. Nonalcoholic steatohepatitis. Semin Liver Dis. 1999;19(2):221–229
  8. Goldstein NS, Hastah F, Galan MV, et al. Fibrosis heterogeneity in nonalcoholic steatohepatitis and hepatitis C virus needle core biopsy specimens. Am J Clin Pathol. 2005;123(3):382–387
  9. Julien B, Grenard P, et al. Antifibrogenic role of the cannabinoid receptor CB2 in the liver. Gastroenterology. 2005;128(3):742–755
  10. Kaser S, Moschen A, Cayon A, et al. Adiponectin and its receptors in non-alcoholic steatohepatitis. Gut. 2005;54(1):117–121
  11. Kisseleva T, Brenner DA. Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis. J Gastroenterol Hepatol. 2007;22(Suppl. 1):S73–S78
  12. Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41(6):1313–1321
  13. Lavine JE, Schwimmer JB. Nonalcoholic fatty liver disease in the pediatric population. Clin Liver Dis 2004;8(3):549–58 [viii–ix].
  14. Ludwig J, Viggiano TR, McGill DB, et al. Nonalcoholic steatohepatitis: mayo clinic experiences with a hitherto unnamed disease. Mayo Clin Proc. 1980;55(7):434–438
  15. Matteoni CA, Younossi ZM, Gramlich T, et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999;116(6):1413–1419
  16. Mendez-Sanchez N, Zamora-Valdes D, Pichardo-Bahena R, et al. Endocannabinoid receptor CB2 in nonalcoholic fatty liver disease. Liver Int. 2007;27(2):215–219
  17. Morra R, Munteanu M, Imbert-Bismut F, et al. FibroMAX: towards a new universal biomarker of liver disease?. Expert Rev Mol Diagn. 2007;7(5):481–490
  18. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology. 2003;37(5):1202–1219
  19. Powell EE, Cooksley WG, Hanson R, et al. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology. 1990;11(1):74–80
  20. Ratziu V, Giral P, Charlotte F, Bruckert E, Thibault V, et al. Liver fibrosis in overweight patients. Gastroenterology. 2000;118(6):1117–1123
  21. Saadeh S, Younossi ZM, Remer EM, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology. 2002;123(3):745–750
  22. Sheth SG, Gordon FD, Chopra S. Nonalcoholic steatohepatitis. Ann Int Med. 1997;126(2):137–145
  23. Siegmund SV, Uchinami H, et al. Anandamide induces necrosis in primary hepatic stellate cells. Hepatology. 2005;41(5):1085–1095
  24. Wanless IR, Shiota K. The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis. Semin Liver Dis. 2004;24(1):99–106
  25. Washington K, Wright K, Shyr Y, et al. Hepatic stellate cell activation in nonalcoholic steatohepatitis and fatty liver. Hum Pathol. 2000;31(7):822–828
  26. Yeh MM, Brunt EM. Pathology of nonalcoholic fatty liver disease. Am J Clin Pathol. 2007;128(5):837–847

PII: S1687-1979(09)00315-3

doi: 10.1016/j.ajg.2009.12.008

Arab Journal of Gastroenterology
Volume 10, Issue 4, Supplement , Pages S17-S20 , April 2010

Article Tools